HTA - 16/167/120

A UK multicentre randomised controlled trial to determine the efficacy of treatments for acute antibody mediated rejection in renal transplantation

Project title: A UK multicentre randomised controlled trial to determine the efficacy of treatments for acute antibody mediated rejection in renal transplantation

Call to action: 16/167 16/167 HTA CET, HTA EoI to Full Form, closing 5 April 2017

Research type: Primary Research

Chief investigator: Dr Michelle Willicombe

Contractor: Imperial College London

Cost: £1,455,032.64

Co-investigators: Dr Candice Roufosse, Dr David Game, Dr Edward Wilson, Dr Lorna Henderson, Dr Menna Clatworthy, Dr Nicholas Torpey, Dr Richard Baker, Dr Sian Griffin, Dr Stephen Marks, Dr Thomas Hiemstra, Mr Frank Clarke, Mr Simon Knight, Professor James Wason.

Started: September 2018 | Status: Research in progress

ISRCTN: 18179652

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.